Keywords

• Dapagliflozin
• Dapagliflozin powder
• 99% Dapagliflozin

Quick Details

• ProName: cas 461432-26-8 99% Dapagliflozin p...
• CasNo: 461432-26-8
• Molecular Formula: C21H25ClO6
• Appearance: white
• Application: Dapagliflozin ?is a new antidiabetic d...
• DeliveryTime: 7-10 days
• PackAge: drum
• Port: Shanghai/Wuhan
• ProductionCapacity: 1000 Kilogram/Day
• Purity: 99
• Storage: room
• LimitNum: 1 Kilogram

Superiority

 cas   461432-26-8  99% Dapagliflozin powder

Details

What is Dapagliflozin  

Dapagliflozin  is a new antidiabetic drug  .  It is also the first approved SGLT2 inhibitor for the treatment of type II diabetes, being an important option in the treatment of diabetes, and is used to improve glycemic control as an adjunct to dietary and exercise for adults with type II diabetes.
Dapagliflozin is a sodium-glucose co-transporter 2 inhibitor. 

Dapagliflozin function

The post-marketing trial requested includes a cardiovascular outcome trial for assessing the cardiovascular risk for high-risk patients after treatment with dapagliflozin at baseline and a study to assess the risk of bladder cancer in recruited patients.  Another study will assess the bladder tumor-promoting effect of this drug on rodent animals.  Two studies will assess the pharmacokinetics, efficacy and safety of dapagliflozin in pediatric patients;  a set of strengthened pharmacovigilance program will monitor liver abnormalities and pregnancy outcome reports in patients receiving daglitazone